BALCHEM CORP (BCPC) Stock Price, Quote, News and Overview
NASDAQ:BCPC - Nasdaq - US0576652004 - Common Stock - Currency: USD
BCPC Quote, Performance and Key Statistics
168.3
-2.15 (-1.26%)
The current stock price of BCPC is 168.3 USD. In the past month the price increased by 6.31%. In the past year, price increased by 9.99%.
BCPC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SHW | SHERWIN-WILLIAMS CO/THE | 31.02 | 88.70B | ||
| ECL | ECOLAB INC | 38.26 | 74.01B | ||
| DD | DUPONT DE NEMOURS INC | 15.76 | 28.42B | ||
| PPG | PPG INDUSTRIES INC | 13.97 | 25.25B | ||
| IFF | INTL FLAVORS & FRAGRANCES | 17.64 | 19.71B | ||
| RPM | RPM INTERNATIONAL INC | 21.95 | 14.49B | ||
| SQM | QUIMICA Y MINERA CHIL-SP ADR | 4.75 | 9.57B | ||
| EMN | EASTMAN CHEMICAL CO | 9.95 | 9.41B | ||
| AXTA | AXALTA COATING SYSTEMS LTD | 13.31 | 6.84B | ||
| ALB | ALBEMARLE CORP | N/A | 6.64B | ||
| NEU | NEWMARKET CORP | 12.83 | 6.08B | ||
| CE | CELANESE CORP | 7.66 | 5.86B |
Related stock screener links
About BCPC
Company Profile
Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,361 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Company Info
BALCHEM CORP
5 Paragon Drive
Montvale NEW JERSEY 10958 US
CEO: Theodore L. Harris
Employees: 1361
Phone: 18453265600
BALCHEM CORP / BCPC FAQ
What is the stock price of BALCHEM CORP today?
The current stock price of BCPC is 168.3 USD. The price decreased by -1.26% in the last trading session.
What is the ticker symbol for BALCHEM CORP stock?
The exchange symbol of BALCHEM CORP is BCPC and it is listed on the Nasdaq exchange.
On which exchange is BCPC stock listed?
BCPC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BALCHEM CORP stock?
8 analysts have analysed BCPC and the average price target is 200.6 USD. This implies a price increase of 19.19% is expected in the next year compared to the current price of 168.3. Check the BALCHEM CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BALCHEM CORP worth?
BALCHEM CORP (BCPC) has a market capitalization of 5.49B USD. This makes BCPC a Mid Cap stock.
How many employees does BALCHEM CORP have?
BALCHEM CORP (BCPC) currently has 1361 employees.
What are the support and resistance levels for BALCHEM CORP (BCPC) stock?
BALCHEM CORP (BCPC) has a support level at 167.11 and a resistance level at 170.74. Check the full technical report for a detailed analysis of BCPC support and resistance levels.
Is BALCHEM CORP (BCPC) expected to grow?
The Revenue of BALCHEM CORP (BCPC) is expected to grow by 6.51% in the next year. Check the estimates tab for more information on the BCPC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BALCHEM CORP (BCPC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BCPC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BCPC, evaluating the profitability, health, valuation and growth aspects
- BALCHEM CORP (BCPC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BALCHEM CORP (BCPC) Sales and EPS estimates to see what analysts future expectations are.
- BALCHEM CORP (BCPC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BALCHEM CORP (BCPC) Insider and Institutional Ownership to learn about the owners and their transactions.
- BALCHEM CORP (BCPC) Stock Chart to make your own analysis
- BALCHEM CORP (BCPC) Latest news and press-releases to stay up to date.
Does BALCHEM CORP (BCPC) stock pay dividends?
BALCHEM CORP (BCPC) has a dividend yield of 0.52%. The yearly dividend amount is currently 0.79. Check the full fundamental report for a detailed analysis of BCPC dividend history, reliability and sustainability.
When does BALCHEM CORP (BCPC) report earnings?
BALCHEM CORP (BCPC) will report earnings on 2025-07-24, before the market open.
What is the Price/Earnings (PE) ratio of BALCHEM CORP (BCPC)?
The PE ratio for BALCHEM CORP (BCPC) is 36.83. This is based on the reported non-GAAP earnings per share of 4.57 and the current share price of 168.3 USD. Check the full fundamental report for a full analysis of the valuation metrics for BCPC.
What is the Short Interest ratio of BALCHEM CORP (BCPC) stock?
The outstanding short interest for BALCHEM CORP (BCPC) is 1.8% of its float. Check the ownership tab for more information on the BCPC short interest.
BCPC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to BCPC. When comparing the yearly performance of all stocks, BCPC is one of the better performing stocks in the market, outperforming 76.38% of all stocks.
BCPC Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to BCPC. BCPC gets an excellent profitability rating and is at the same time showing great financial health properties.
BCPC Financial Highlights
Over the last trailing twelve months BCPC reported a non-GAAP Earnings per Share(EPS) of 4.57. The EPS increased by 12.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.16% | ||
| ROA | 8.44% | ||
| ROE | 11.3% | ||
| Debt/Equity | 0.16 |
BCPC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to BCPC. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 18.18% and a revenue growth 6.51% for BCPC